Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Caroline Illmann"'
Publikováno v:
Archives of Breast Cancer, Vol 9, Iss 2 (2022)
Background: Health literacy (HL) is an individual’s ability to interpret and effectively utilize health information. Low HL has been associated with poorer treatment adherence. The effect of HL on treatment adherence is important to understand when
Externí odkaz:
https://doaj.org/article/fd23afc0e07541b5a805baa4f8a88e6b
Autor:
Caroline A. Lohrisch, Nathalie LeVasseur, S Baxter, Walter Yip, Caroline Illmann, K Dobosz, Christine E. Simmons, Kaylie-Anne Willemsma
Publikováno v:
Current Oncology
Volume 27
Issue 2
Pages 5635-92
Curr Oncol
Volume 27
Issue 2
Pages 5635-92
Curr Oncol
The use of Oncotype dx (Genomic Health, Redwood City, CA, U.S.A.) testing has been shown to change treatment decisions in approximately 30% of breast cancer (bca) cases, but research on how Recurrence Score testing has affected the type of chemothera
Autor:
Kaylie Willemsma, Nathalie LeVasseur, Caroline Illmann, Christine Simmons, Lauren Corke, Miranda Mcdermott, Lidiya Luzhna, Christine Wilson
Background With the increasing use of neoadjuvant treatment (NAT) for patients with early-stage breast cancer (ESBC), adequate clinical staging is essential to inform treatment. While the use of MRI with NAT has been proposed to help with accuracy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0199fbd0bf4051ce4984ffcee89fb28b
https://doi.org/10.21203/rs.3.rs-1062339/v1
https://doi.org/10.21203/rs.3.rs-1062339/v1
Publikováno v:
Journal of Clinical Oncology. 35:e12049-e12049
e12049 Background: The Oncotype DX test has been shown to change treatment plans in ~30% of cases, but it is unclear if it changes the type of chemotherapy offered. We sought to determine if the availability of Oncotype DX testing in BC resulted in a
Autor:
Kaylie Willems, Miranda Mcdermott, Caroline Illmann, Christine E. Simmons, Walter Yip, Huaqi Li, Nathalie LeVasseur
Publikováno v:
Journal of Clinical Oncology. 35:581-581
581 Background: While neoadjuvant chemotherapy (NACT) has been established as the standard of care for medically fit patients, there has been renewed interest in utilizing neoadjuvant endocrine therapy (NET) for the treatment of women with estrogen-r
Publikováno v:
Journal of Clinical Oncology. 34:6546-6546
6546Background: Several studies suggest that wait time from diagnosis to surgery and from surgery to chemotherapy may impact outcome in the adjuvant treatment of breast cancer. Many patients referr...
Autor:
Caroline Illmann, Elaine McKevitt, Maryam Eslami, Rebecca Warburton, Christine Simmons, Rachel Adilman
Publikováno v:
Journal of Clinical Oncology. 34:208-208
208 Background: Breast cancer management has become exceedingly collaborative across specialties. Preoperative multidisciplinary input in particular is increasingly needed as indications for neoadjuvant therapy (NAT) continue to expand. In British Co